HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever Innovation, Speed To Market Drive Q2 Gains In Personal Care

This article was originally published in The Rose Sheet

Executive Summary

Unilever PLC’s personal-care turnover increased 4.1% in the second quarter, benefiting in part from “bigger, better” innovations including Dove Repair Expertise, which rolled out to 12 countries. Firm has also scaled down its portfolio by 20%.

You may also be interested in...



Unilever Looks To Personal-Care Innovation, Improved “Agility” In FY 2014

Unilever reports a 3% decline in FY 2013 turnover, but underlying sales growth was ahead of market, the firm says, crediting strong innovation in personal care and successes in emerging markets, among other factors. Going forward the firm aims to create efficiencies via SKU reductions and other streamlining efforts.

Unilever Invests In IOMA Luxury Skin Care, Diagnostics

Unilever enters a strategic investment alliance with Paris-based skin-care company IOMA, which uses skin-analysis systems at point of sale to offer personalized regimens and demonstrate product efficacy.

In Brief

FDA says it continues to consider the Personal Care Products Council’s 2011 petition requesting guidance regarding safe levels of lead in cosmetic products; Hong Kong-based firm Li & Fung Limited acquires Lornamead for $190 million. More new in brief.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018665

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel